Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT03140358
PHASE3
The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)
Sponsor: Singapore National Eye Centre
View on ClinicalTrials.gov
Summary
Study of low dose atropine in preventing the onset and progression of myopia in high risk children with pre-myopia or low-myopia.
Key Details
Gender
All
Age Range
5 Years - 9 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2017-04-21
Completion Date
2025-12-31
Last Updated
2025-05-18
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Atropine sulfate 0.01%
Atropine 0.01%
DRUG
Placebo
placebo
Locations (1)
Singapore eye research institute
Singapore, Singapore